CA2182272A1 - Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine - Google Patents

Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine

Info

Publication number
CA2182272A1
CA2182272A1 CA002182272A CA2182272A CA2182272A1 CA 2182272 A1 CA2182272 A1 CA 2182272A1 CA 002182272 A CA002182272 A CA 002182272A CA 2182272 A CA2182272 A CA 2182272A CA 2182272 A1 CA2182272 A1 CA 2182272A1
Authority
CA
Canada
Prior art keywords
protein
papilloma virus
formed therefrom
vlps formed
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002182272A
Other languages
English (en)
Other versions
CA2182272C (fr
Inventor
Ian Frazer
Jian Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
CSL Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPM3588A external-priority patent/AUPM358894A0/en
Application filed by Individual filed Critical Individual
Publication of CA2182272A1 publication Critical patent/CA2182272A1/fr
Application granted granted Critical
Publication of CA2182272C publication Critical patent/CA2182272C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002182272A 1994-01-31 1995-01-31 Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine Expired - Lifetime CA2182272C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM3588 1994-01-31
AUPM3588A AUPM358894A0 (en) 1994-01-31 1994-01-31 Modified papilloma virus l2 protein and vlps formed therefrom
PCT/AU1995/000043 WO1995020659A1 (fr) 1994-01-31 1995-01-31 Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine

Publications (2)

Publication Number Publication Date
CA2182272A1 true CA2182272A1 (fr) 1995-08-03
CA2182272C CA2182272C (fr) 2006-03-21

Family

ID=36101487

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002182272A Expired - Lifetime CA2182272C (fr) 1994-01-31 1995-01-31 Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine

Country Status (1)

Country Link
CA (1) CA2182272C (fr)

Also Published As

Publication number Publication date
CA2182272C (fr) 2006-03-21

Similar Documents

Publication Publication Date Title
WO2003078455A3 (fr) Vaccin
WO1996011272A3 (fr) Particules semblables au virus du papillome, proteines de fusion et leur procede de production
CA2189882A1 (fr) Vaccins contre le papillomavirus
DE122011100018I1 (de) Herstellung von menschlichem Papilloma-Virus-Capsid-Protein und virusahnlichen Teilchen.
EP2330129A3 (fr) Anticorps anti-TNF, compositions, procédés et utilisations
DK0862633T3 (da) VP-antigen af JC-virus
EA199700281A1 (ru) Молекула днк, кодирующая белок l1 вируса папилломы типа 11 чепловека, экспрессирующий вектор, способ получения очищенных вирусоподобных частиц
CA2305471A1 (fr) Amidon de composition modifiee pour extraire des particules de dispersions aqueuses
WO1995021922A3 (fr) Reactifs pour l'hepatite non-a, non-b, non-c, non-d et procede pour leur utilisation
WO1996029413A3 (fr) Adn codant le virus du papillome de type 18 humain
AUPM358894A0 (en) Modified papilloma virus l2 protein and vlps formed therefrom
EP1637604A3 (fr) Procédé de production des protéines
CA2182272A1 (fr) Proteine l2 modifiee du virus du papillome, et viroides formes a partir de cette proteine
EP0834560A4 (fr) Particules magnetiques fines contenant des proteines utiles auxquelles elles sont liees, procede de production et utilisation de ces particules
CA2270408A1 (fr) Anticorps monoclonal contre l'epitope ypyvpdya, son procede de production et son utilisation
CA2237224A1 (fr) Particules synthetiques de type viral hpv11
WO1997004099A3 (fr) Papillomavirus, agents de depistage de ceux-ci et de therapie de maladies causees par ces virus
CA2025678A1 (fr) Delta-lactones naturels et procede de production
CA2199403A1 (fr) Nouvelles proteines fixant la proteine kinase a (pka) et leur utilisation
CA2213742A1 (fr) Methode pour preparer un plasma deficient en facteur v; plasma deficient ainsi obtenu
CA2199843A1 (fr) Proteine se fixant a une kinase et ses utilisations
CA2256696A1 (fr) Petits virus a arn modifies
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
CA2329144A1 (fr) Nouveaux fragments peptidiques pour la purification de proteines
AU4457397A (en) Model for the papilloma virus infection (in vivo), consisting of the scid-bo mouse

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150202